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OBJECTIVES: We aimed to explore the effects of diet on the inflammatory response in middle-aged and elderly
people with hypertension.
METHODS: Thirty overweight or obese patients with stage one hypertension (age range, 45-75 years) were
allocated to either the intervention or control group (n=15 per group; age- and sex-matched). Patients in the
intervention group consumed a food powder supplement (100 g) instead of a regular meal. The control group
maintained their normal dietary habits. This study lasted for six weeks. Blood pressure, inflammatory marker
levels, and energy intake were measured before and after the study.
RESULTS: After 6 weeks, the diet composition of the intervention group changed significantly (po0.05). The
intake of proteins, dietary fibre, monounsaturated fat, and polyunsaturated fat increased significantly
(po0.05), while the total energy intake trended towards an increase (p40.05). In the control group, the total
energy intake decreased significantly (po0.05). The levels of nuclear factor-kB (NF-kB), soluble intercellular
adhesion molecule-1 (sICAM-1) and high sensitivity C-reactive protein (hs-CRP) decreased, and adiponectin
increased significantly in the intervention group (po0.05); however, no significant changes were observed in
the inflammatory marker levels of the control group. In the intervention group, systolic blood pressure
decreased significantly (po0.05), and diastolic blood pressure also exhibited a decreasing trend. No significant
change in blood pressure was observed in the control group.
CONCLUSION: The consumption of a food powder supplement can improve diet composition, decrease blood
pressure and reduce inflammation in middle-aged and elderly overweight or obese hypertensive patients. The
food powder supplement may also have an anti-atherosclerotic effect in hypertensive patients.
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’ INTRODUCTION
In recent years, an estimated 31.1% of the global
population, or approximately 13.4-14.4 billion people, have
been affected by hypertension (1). In our previous study,
the prevalence of hypertension in the Zhangfang Village of
the Fangshan District was found to be 59.1% (2). Studies
have shown that the prevalence of hypertension in middle-
and low-income countries (31.5%) is higher than that in high-
income countries (28.5%) (1). Moreover, the prevalence of
hypertension in rural areas (35.1%) is higher than that in
urban areas (32.1%) (3). The rate of controlled hypertension
in Canada and the United States is above 60% (4,5).
The control of hypertension in China is significantly poorer
than that in other countries.
The main treatment methods for hypertension are drug, life-
style and dietary interventions. Several studies have evaluated
drug treatment and the influence of lifestyle changes on hyper-
tension; however, few studies have evaluated the influence
of diet composition on hypertension. In fact, a balanced diet,
nutritional supplements and a healthy lifestyle have equivalent
blood pressure-lowering effects (6).
A wide body of evidence shows that hypertension is, in
essence, a low-level inflammatory response (7). The inflam-
matory response plays an important role in the pathogenesis
of hypertension (7). The activation of nuclear factor-kB (NF-kB)
has been shown to contribute to vascular endothelial dys-
function and increased blood pressure levels (8). High sensi-
tivity C-reactive protein (hs-CRP) is believed to be involved
in the pathogenesis of insulin resistance, diabetes mellitus
and metabolic syndrome, which includes hypertension (9);
it has been suggested that elevated hs-CRP should be added
to the criteria for the identification of metabolic syndrome.
Serum intercellular cell adhesion molecule-1 (sICAM-1) isDOI: 10.6061/clinics/2019/e890
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associated with atherosclerosis and influences blood pressure
levels (10). Hence, suppression of the inflammatory response
is a key challenge in the treatment of hypertension.
Hypertensive patients can benefit from a balanced diet (6).
In contrast, an unbalanced diet can promote the inflammatory
response and/or lack the components that prevent this inflam-
matory response, which can further lead to hypertension.
An unbalanced diet may contain high sodium, low potas-
sium, high energy (e.g., high fat, high carbohydrate) and low
protein. A high-sodium diet is a known risk factor for hyper-
tension (11,12). A low-potassium diet elevates blood pressure
(13). High energy intake is a risk factor for hypertension.
When the energy intake exceeds the recommended intake by
420%, the risk of hypertension has been shown to increase
1.7-fold (14). Moreover, dietary sources of energy (proportion
of energy from fats, proteins or carbohydrates) are also key
dietary factors that may lead to elevated blood pressure. Fat is
a pro-inflammatory nutrient, and high fat intake is a risk
factor for hypertension (15). High carbohydrate intake is also
associated with a high prevalence of hypertension, as shown
in our preliminary study (16). Studies conducted overseas
have also shown that compared to a low-fat diet, a low-carbo-
hydrate diet can decrease the level of inflammatory markers
(17), and the level of inflammatory markers is closely linked to
hypertension (18). Inadequate protein intake can also cause
high blood pressure. Sugar intake is also positively associated
with hypertension (19).
Diets in rural areas are typically high in energy (high-
carbohydrate diets composed of white rice and pickles), low
in protein and devoid of fruits and vegetables (16). Diets in
rural areas have higher sodium contents and lack protein,
taurine, calcium, magnesium, phosphorus and other nutri-
ents. This unbalanced diet is related to blood pressure (20).
Western guidelines for the prevention and treatment of
hypertension include dietary recommendations such as
the Dietary Approach to Stop Hypertension (DASH) diet
(class B) (21,22) and the Japanese guidelines for hyperten-
sion management, which recommend (23) the Mediterranean
diet. The Mediterranean dietary pattern includes increased
intake of vegetables, fruits, fish and oils and reduced intake
of cholesterol and saturated fatty acids. Alternatively, the
hypertension guidelines in China recommend only restric-
tion of the dietary intake of sodium and contain no other
dietary recommendations (24). Therefore, we should pay full
attention to dietary management as an integral component of
the management of hypertension. Although the DASH diet
and Mediterranean diet have a definite effect on reducing
blood pressure, these dietary patterns are difficult to adopt in
China, especially in rural areas.
The present study aimed to investigate the effects of a
dietary supplement on blood pressure and inflammatory
marker expression in middle-aged and elderly hypertensive
people. We hope to develop a feasible dietary intervention
model that can help reduce the prevalence of hypertension in
rural areas of China.
’ MATERIALS AND METHODS
Participants
Thirty hypertensive patients who were overweight or
obese (age range, 45 to 75 years) were enrolled in the study
from 27 June 2015 to 15 August 2015. All of the patients
were from the Zhangfang Village of the Fangshan District
in Beijing.
The inclusion criteria were as follows: (1) body mass index
(BMI)424.0 kg/m2 (24.0oBMIo28.0 kg/m2 defined as over-
weight; BMI X28.0 kg/m2 defined as obese); (2) systolic
blood pressure between 140 and 159 mmHg (1 mmHg=
0.133 kPa), and/or diastolic blood pressure between 90 and
99 mmHg; and (3) diagnosis of stage 1 hypertension and
absence of medical treatment for hypertension.
The exclusion criteria were as follows: (1) hepatic and renal
insufficiency, (2) cognitive impairment, (3) mental abnorm-
ality, (4) pregnancy or lactation, (5) alcoholism (daily intake
of liquor4150 g/d or beer4500 mL/d), (6) irregular dietary
habits or inability of maintaining a dietary intervention. The
patients were divided into the intervention group (IG) and
control group (CG) and were matched by age, sex and BMI.
This trial was registered with the Chinese Clinical Trial
Registry (Number ChiCTR1800014475). The study was
approved by the ethical committee of the local hospital.
Written informed consent was obtained from all participants.
Materials
The dietary supplement used in this study is called ‘‘Special
Food Powder from Nuts and Seeds (SFPNS)’’. It was devel-
oped by the Department of Nutrition at the Beijing Friendship
Hospital of Capital Medical University. The formulation is
patented under national patent protection (patent number:
201310706278.6). The components of the dietary supplement
include rye, black rice, walnuts, lotus seeds, black beans,
yams, American ginseng and Chinese dates. The recom-
mended daily intake of the dietary supplement is 77 g, which
contains 14 g rye, 7 g black rice, 14 g walnuts, 14 g lotus seeds,
14 g black beans, 7.5 g yams, 2.5 g American ginseng, 4 g
Chinese dates; and provides 293 kcal energy, 13 g protein
(17.75%), 40 g carbohydrates (54.61%), and 9 g fat (27.644%).
Study design
On 27 June 2015, all 30 participants were counselled about
the dietary supplement and informed about the study
methods before the beginning of this trial. All participants
underwent an initial taste test of the dietary supplement. The
period from 28 June 2015 to 4 July 2015 was the adaptation
period. In this period, all participants in the two groups
consumed their original diets, and the dietary intake over the
course of three days (including 2 work days and 1 weekend
day) and physical activity over the course of two days were
recorded. On 4 July 2015, the blood pressure of the parti-
cipants was measured, and the blood levels of inflammatory
markers (including NF-kB, sICAM-1, hs-CRP and adiponec-
tin) were determined; in addition, a detailed dietary survey
was conducted (18). The intervention trial period was from
5 July 2015 to 15 August 2015. Participants in the IG were
administered 77 g SFPNS every day instead of 100 g of their
regular meal, while participants in the CG maintained their
original diet. None of the participants in the two groups
received any drug treatments; all participants maintained
their original lifestyle during the study period. Six weeks
later, blood pressure and the levels of inflammatory markers
were measured again. Additionally, another detailed dietary
survey was conducted.
Biochemical assessment
After 12h of overnight fasting, 10 mL venous blood samples
were obtained and immediately centrifuged at 2500  g for
10 min at 4oC. NF-kB, sICAM-1 and adiponectin were estimated
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via ELISA, and hs-CRP was measured by immune turbidimetry.
These indices were measured by the Beijing Institute of Clinical
Laboratory Limited.
Diet survey
We used a 24-h dietary recall survey method to collect the
participants’ dietary histories. Subsequently, the integrated
traditional Chinese and Western medicine nutritional treat-
ment expert system (NCCW2011) nutrition analysis software
was used to analyze the intake of total energy, carbohy-
drates, proteins, fat, dietary fibre, selenium, zinc, vitamin B1,
monounsaturated fatty acids and polyunsaturated fatty acids.
Statistical analysis
Prior to statistical analysis, the normality of the distribu-
tion of all variables was assessed using the Kolmogorov-
Smirnov test, histograms and p-p plots. If needed, the data
were log (ln) transformed to achieve a normal distribution.
Descriptive statistics (mean, SD, and range) of the gen-
eral characteristics of the study participants are reported.
Between-group differences with respect to sex, smoking,
and alcohol consumption were assessed by the chi-squared
test. Data pertaining to dietary intake, lipid levels, age,
physical activity and sleep duration were compared by
t tests.
Quality control method
During the study period, nutritionists conducted detailed
dietary surveys and provided guidance to all participants.
The nutritionists performed a telephone survey 2-3 times per
week and detected dietary changes on time and guided the
participants in accordance with the requirements of the study
diet procedure. The village committee appointed a specific
person to distribute the dietary supplement and established
the registration procedure.
’ RESULTS
All 15 participants in the IG tolerated the dietary supple-
ment and experienced no allergic reactions. In total, 22 patients
(10 patients in the IG, 12 patients in the CG) completed the
study. In the IG, 5 participants withdrew from the study
because of surgery, overseas travel, or personal reasons. In the
CG, 3 participants withdrew because of personal reasons.
No significant between-group differences were observed
with respect to sex, age, smoking, alcohol consumption,
physical activity of sleep duration at baseline (p40.05 for all;
Table 1).
Before the experiment, the blood pressure levels in the two
groups were not significantly different (p40.05; Table 2 and
Figure 1). After the 6-week experiment, the systolic blood
pressure of the IG showed a significant decrease compared to
that of the CG (po0.05; Table 2 and Figure 1). The diastolic
blood pressure also showed a decreasing trend; however,
the between-group difference was not statistically significant
(po0.1; Table 2 and Figure 1). In the CG, the systolic and
diastolic blood pressure at the completion of the experiment
were not significantly different from the baseline levels
(p40.05; Table 2 and Figure 1).
The levels of inflammatory markers, including NF-kB,
sICAM-1, hs-CRP and adiponectin, in the two groups before
and after the experiment are summarized in Table 3 and
Figure 2. Before the experiment, no significant between-
group differences were observed with respect to the levels
of inflammatory markers (all p40.05). After the 6-week exp-
eriment, the levels of NF-kB, sICAM-1, and hs-CRP in the
IG decreased significantly (all po0.05), while the adiponec-
tin level was significantly higher than the baseline level
(po0.05). In the CG, the levels of NF-kB and sICAM-1
showed a decreasing trend (p40.05), while the adiponectin
level showed an increasing trend (p40.05); however, the
changes were not statistically significant. In the CG, only the
hs-CRP level showed a significant decrease (po0.05).
Table 1 - General characteristics of the patients in the two groups.
Group N Sex
(Male/Female)
Age
(y)
Smoking@
(Y/N)
Alcohol&
(Y/N)
Exercise#
(h/d)
Sleep
(h/d)
IG 10 5/5 57.7±8.2 5/5 5/5 0.9±0.3 7.4±2.1
CG 12 6/6 60.8±7.8 6/6 6/6 1.2±0.4 7.1±1.4
T -* -0.420 -* -* -0.519 0.861
p 1.000 0.701 1.000 1.000 0.560 0.401
Note: IG, intervention group; CG, control group; *Fisher’s exact probability method; &daily consumption of alcohol in any form; #time spent exercising,
including heavy physical labour and physical exercise.
Table 2 - Comparison of blood pressure between the two groups.
SBP DBP
Group N before after t p before after t p
IG 10 140±15 128±9 2.998 0.008 81±15 77±10 1.989 0.069
CG 12 142±16 145±14 -0.812 0.425 83±21 83±8 0.269 0.790
T - -0.504 -3.014 - - -0.696 -1.859 - -
p - 0.602 0.007 - - 0.492 0.089 - -
Data are presented as the mean ± standard deviation (mmHg).
Note: SBP, systolic blood pressure; DBP, diastolic blood pressure; before, the data before the experiment; after, the data after the 6-week experiment;
IG, intervention group; CG, control group.
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The comparisons of energy intake and the proportions of
nutrient components between the two groups before and
after the study are summarized in Table 4 and Figure 3.
Before the experiment, the total energy and nutrient intakes
showed no significant between-group differences (both
p40.05). Following the 6-week experiment, in the IG, the
proportion of protein increased significantly (po0.05), while
the proportion of carbohydrates showed a decreasing trend
(p40.05). In addition, the intakes of dietary fibre, mono-
unsaturated fatty acids, and polyunsaturated fatty acids
increased significantly (po0.05). In the CG, the energy intake
decreased significantly (po0.05); however, no significant
change in the proportion of fibres, monounsaturated fatty
acids, and polyunsaturated fatty acids was observed (p40.05).
’ DISCUSSION
In this study, we first demonstrated that dietary improve-
ments (such as an increase in the proportion of proteins,
increased intake of fibres and unsaturated fatty acids)
without a reduction in total energy intake can reduce the
levels of inflammatory markers in middle-aged and elderly
hypertensive patients. In the study population, the levels of
NF-kB, sICAM-1 and hs-CRP were decreased significantly,
and the blood level of adiponectin increased significantly
after consuming the dietary supplement produced by the
Department of Nutrition at Beijing Friendship Hospital of
Capital Medical University. In addition, the systolic blood
pressure markedly declined, and the diastolic blood pressure
slightly declined after the dietary supplement intervention.
In addition, the reduction in total energy intake alone, with-
out a concomitant change in diet composition, significantly
reduced hs-CRP levels; however, no significant changes in
systolic and diastolic blood pressure, NF-kB or sICAM-1
were observed.
Our results differ from those of previous studies. In a
study by Witkowska (10) conducted on 22 obese postmeno-
pausal women, the restriction of energy intake (1,200 kcal/d)
and the consumption of a low-fat, high-carbohydrate diet led
to a mean weight reduction of 6 kg, along with decreased
hs-CRP and increased adiponectin levels. These results
showed that in obese patients, restricted energy intake and
a low-fat, high-carbohydrate diet can decrease the level
of inflammatory markers and lead to weight loss. Some
scholars have confirmed that improving the diet can decrease
the level of inflammatory markers. Forsythe et al. (17) found
that in metabolic syndrome patients, compared to an energy-
restricted, low-fat, high-carbohydrate diet (LED), an energy-
restricted, very low-carbohydrate diet (VLCKD) increased the
level of arachidonic acid, improved inflammatory marker
levels and significantly decreased the level of sICAM-1. In a
study by Zou et al. (25), limiting the energy intake alone
attenuated oxidative stress and decreased the production of
soluble adhesion molecules. Medina-Remon et al. (26) repor-
ted that dietary supplementation with nuts can increase the
intake of polyphenols and decrease the level of inflammatory
Table 3 - Comparison of inflammatory markers between the two groups.
NF-kB (ng/L) sICAM-1 (mg/L)
Group N T0 T1 t p T0 T1 t p
IG 10 248.2±89.7 161.7±87.3 2.218 0.041 138.5±79.1 102.7±54.8 2.201 0.045
CG 12 235.4±91.4 201.5±79.4 0.861 0.239 132.6±69.5 128.8±64.9 0.997 0.327
t - 0.284 -1.521 - - 0.197 -2.171 - -
p - 0.724 0.158 - - 0.892 0.295 - -
Adiponectin (mg/L) hs-CRP (mg/L)
Group N T0 T1 t p T0 T1 t p
IG 10 2964.1±1364.1 4874.3±1349.7 2.221 0.039 3.2±1.9 1.4±0.3 2.289 0.036
CG 12 3049.2±1695.1 3849.7±1210.4 1.391 0.189 3.5±1.2 1.9±0.8 2.105 0.048
t - -0.197 2.291 - - -0.695 -0.910 - -
p - 0.893 0.035 - - 0.529 0.361 - -
Data are presented as the mean ± standard deviation.
Figure 1 - Comparison of blood pressure between the two groups.
SBP, systolic blood pressure; DBP, diastolic blood pressure; Intervene, intervention group; Control, control group; T0, the data before
the experiment; T1, the data after the experiment.
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Table 4 - Comparison of total energy intake and proportions of different nutrients between the two groups before and after the
study.
Group N Energy (kcal) Carbohydrates (%)
T0 T1 t p T0 T1 t p
IG 10 2033.7±437.5 2196.5±211.5 -1.500 0.149 56.9±10.8 49.2±8.1 1.980 0.075
CG 12 2098.5±427.7 1549.2±357.3 3.138 0.004 57.1±11.2 56.5±9.8 0.658 0.514
t - -0.274 4.297 - - -0.326 -1.761 - -
p - 0.759 o0.001 - - 0.787 0.092 - -
Group N Protein (%) Fat (%)
T0 T1 t p T0 T1 t p
IG 10 9.5±4.6 15.9±6.8 3.407 0.003 33.5±16.6 34.9±12.1 -0.228 0.743
CG 12 8.9±5.9 9.0±5.4 -1.289 0.231 34.1±14.3 34.5±9.1 -0.591 0.528
t - 0.295 5.874 - - -1.961 1.038 - -
p - 0.846 o0.001 - - 0.076 0.310 - -
Group N Dietary Fibre (g) Monounsaturated Fatty Acids (g)
T0 T1 t p T0 T1 t p
IG 10 20.2±7.9 26.9±9.3 -3.465 0.003 16.3±3.1 19.4±6.2 -2.140 0.045
CG 12 19.2±8.2 17.6±5.7 0.230 0.820 16.9±3.4 15.8±4.4 1.069 0.308
t - 1.197 6.725 - - -0.552 2.085 - -
p - 0.322 o0.001 - - 0.635 0.049 - -
Group N Polyunsaturated Fatty Acids (g)
T0 T1 t p
IG 10 18.5±7.4 26.7±6.0 -3.434 0.003
CG 12 18.5±6.1 15.3±5.4 1.429 0.166
t - -0.056 4.906 - - - -
p - 0.956 o0.001 - - - -
Note: IG, intervention group; CG, control group; T0, the data before the experiment; T1, the data after the experiment; carbohydrate (%), the proportion
of total energy from carbohydrates; protein (%), the proportion of total energy from protein; fat (%), the proportion of total energy from fats.
Figure 2 - Comparison of inflammatory markers between the two groups.
Intervene, intervention group; Control, control group; T0, the data before the experiment; T1, the data after the experiment.
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Figure 3 - Comparison of total energy intake and proportions of different nutrients between the two groups before and after
the study.
Intervene, intervention group; Control, control group; T0, the data before the experiment; T1, the data after the experiment.
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markers (VCAM-1, ICAM-1, IL-6, TNF-a) and blood pressure.
These findings are consistent with those of the present study.
These results suggest that dietary improvements are more
important than mere restriction of energy intake in middle-
aged and elderly hypertensive patients.
The dietary supplement used in this study is rich in grains
and beans; moreover, it has a higher content of protein, dietary
fibre and unsaturated fatty acids than a meal of white rice and
pickles. with the consumption of this dietary supplement
effectively improved the diet composition in the IG. While
there was no significant change in the total energy intake, the
proportions of protein, dietary fibre, and unsaturated fatty
acids increased significantly. In the CG, there was no dietary
intervention; however, the total energy intake decreased. We
believe that this is largely attributable to seasonal factors.
The study period spanned from July to August, when the
temperature and humidity in Beijing are very high. These
factors likely affected the appetite of the participants and
reduced their total energy intake; however, the dietary com-
position did not change in terms of the proportion of protein,
dietary fibre, and unsaturated fatty acids. In contrast, the
energy intake in the IG showed an increasing trend due to
the consumption of the supplement, which is rich in nuts and
seeds and can improve appetite. Therefore, in the IG, the
participants had a higher energy intake (26).
Several likely mechanisms may explain the anti-inflam-
matory and antihypertensive effects of the dietary supple-
ment. First, the consumption of the dietary supplement
increased protein intake and concomitantly decreased in the
proportion of carbohydrates consumed. A diet that is rela-
tively low in carbohydrates can increase the level of ketones,
which in turn may attenuate oxidative stress and improve
vascular endothelial function. Second, the high fibre content
in the dietary supplement can stabilize blood glucose levels
and reduce cholesterol absorption in vivo. Third, unsatu-
rated fatty acids can regulate blood lipid levels, which can
effectively improve endothelial function, reduce the inflam-
matory reaction of blood vessels, and play a role in decreasing
blood pressure (17). Therefore, in the CG, a reduction in the
total energy intake without improvement in diet composition
did not adequately reduce the inflammatory reaction. More-
over, sICAM-1 is a marker of vascular inflammation. The level
of sICAM-1 can reflect the activation level of endothelial cells
and the degree of atherosclerosis (25). Malnutrition is closely
related to sICAM-1.
NF-kB and some protein molecules regulated by NF-kB,
such as adhesion molecules, integrin, and E-selectin, parti-
cipate in vascular inflammation and cause vascular endothe-
lial dysfunction. Malnutrition, such as excessive consump-
tion of saturated fatty acids, trans-fatty acids, and energy, can
activate NF-kB and increase the level of adhesion molecules,
whereas other molecules, such as a-linolenic acids, unsaturated
fatty acids, selenium, and soluble dietary fibre, can inhibit
NF-kB. Under normal conditions, in vascular endothelial cells,
NF-kB is activated first, then levels of the adhesion molecules
increase, activating NF-kB in mononuclear macrophages, which
further increases the levels of adhesion molecules (27).
Adiponectin, which is an insulin-sensitizing hormone, can
increase fatty acid oxidation and glucose uptake in skeletal
muscle cells. Additionally, adiponectin can significantly
increase the inhibitory effect of insulin on gluconeogenesis
and inhibit glucose production in the liver; moreover, adi-
ponectin is an important regulatory factor in lipid metabo-
lism and glucose homeostasis. Plasma levels of adiponectin
showed a negative correlation with the levels of triglycerides
(TGs) and low-density lipoprotein cholesterol (LDL-C) and a
positive correlation with the level of high-density lipoprotein
cholesterol (HDL-C). Studies conducted by Ouch et al. (28)
and Shibata et al. (29) have shown that adiponectin can
decrease adhesion in monocytes and decrease the expression
of many adhesion molecules in vascular endothelial cells,
such as VCAM-1, ICAM-1 and E-selectin. NF-kB is an impor-
tant factor that stimulates the transcriptional regulation of
VCAM-1, ICAM-1 and E-selectin. Adiponectin may regulate
the function of endothelial cells by inhibiting the NF-kB
signalling pathway, and TNF-a may specifically inhibit this
activation.
The limitations of the study
The sample size was small, and the test period was six
weeks, which is relatively short. The study was not completed
in one season, and the season may have affected the appetite
of the participants and, thus, the results. In our study,
although the participants in the IG consumed the dietary
supplement, their diets did not reach the standard of a high-
protein, low-carbohydrate diet, which may have compro-
mised the accuracy of the results. Further study is needed to
validate these findings.
’ CONCLUSION
In our study, the energy intake in the IG did not change;
however, the diet composition improved. In the CG, the
energy intake decreased significantly; however, the diet
composition did not improve. Our experiment was carried
out in the summer, and the weather had an important impact
on the diet. Additional studies involving a reduced energy
diet with simultaneous dietary composition improvements
are required. Further studies will be conducted in which the
participants will be provide with all of their food to control
the total energy intake and improve the diet composition
through the consumption of a dietary supplement, and then
the changes in inflammatory marker levels and blood pres-
sure will be observed.
In summary, in overweight and obese urban residents
with hypertension, improving diet composition by consum-
ing a special dietary supplement can reduce the expression
of inflammatory markers and decrease blood pressure. The
consumption of a dietary supplement may be recommended
as a strategy for the control of hypertension.
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